Taysha Gene Therapies
TSHA
#6714
Rank
โ‚ฌ0.46 B
Marketcap
2,25ย โ‚ฌ
Share price
46.63%
Change (1 day)
80.94%
Change (1 year)

EPS for Taysha Gene Therapies (TSHA)

EPS in 2023 (TTM): -2,18ย โ‚ฌ

According to Taysha Gene Therapies's latest financial reports the company's current EPS (TTM) is -2,16ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -3,58ย โ‚ฌ an increase over its 2021 EPS that were of -4,36ย โ‚ฌ.

EPS history for Taysha Gene Therapies from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-2,18ย โ‚ฌ-39.08%
2022-3,58ย โ‚ฌ-17.93%
2021-4,36ย โ‚ฌ69.11%
2020-2,58ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-2,05ย โ‚ฌ-4.80%๐Ÿ‡บ๐Ÿ‡ธ USA